ChemoMetec A/S Financials

CHY Stock  EUR 70.20  0.20  0.29%   
Financial data analysis helps to double-check if markets are presently mispricing ChemoMetec A/S. We were able to interpolate thirty available fundamental indicators for ChemoMetec AS, which can be compared to its peers. The stock experiences a normal upward fluctuation. Check odds of ChemoMetec A/S to be traded at €73.71 in 90 days.
  
Understanding current and past ChemoMetec A/S Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ChemoMetec A/S's financial statements are interrelated, with each one affecting the others. For example, an increase in ChemoMetec A/S's assets may result in an increase in income on the income statement.

ChemoMetec A/S Stock Summary

ChemoMetec A/S competes with Pembina Pipeline, Harmony Gold, GREENX METALS, Treasury Wine, and Fortescue Metals. ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis in Denmark, the United States, Canada, rest of Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. CHEMOMETEC operates under Scientific Technical Instruments classification in Germany and is traded on Frankfurt Stock Exchange. It employs 147 people.
Foreign Associate
  USA
InstrumentGermany Stock View All
ExchangeFrankfurt Exchange
ISINDK0060055861
Business AddressGydevang 43, Allerd,
SectorTechnology
IndustryScientific & Technical Instruments
BenchmarkDow Jones Industrial
Websitechemometec.com
Phone45 48 13 10 20
CurrencyEUR - Euro
You should never invest in ChemoMetec A/S without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ChemoMetec Stock, because this is throwing your money away. Analyzing the key information contained in ChemoMetec A/S's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

ChemoMetec A/S Key Financial Ratios

There are many critical financial ratios that ChemoMetec A/S's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ChemoMetec A/S reports annually and quarterly.

ChemoMetec Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ChemoMetec A/S's current stock value. Our valuation model uses many indicators to compare ChemoMetec A/S value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ChemoMetec A/S competition to find correlations between indicators driving ChemoMetec A/S's intrinsic value. More Info.
ChemoMetec AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.64  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ChemoMetec AS is roughly  1.56 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ChemoMetec A/S's earnings, one of the primary drivers of an investment's value.

ChemoMetec A/S Systematic Risk

ChemoMetec A/S's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ChemoMetec A/S volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on ChemoMetec A/S correlated with the market. If Beta is less than 0 ChemoMetec A/S generally moves in the opposite direction as compared to the market. If ChemoMetec A/S Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ChemoMetec A/S is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ChemoMetec A/S is generally in the same direction as the market. If Beta > 1 ChemoMetec A/S moves generally in the same direction as, but more than the movement of the benchmark.

ChemoMetec A/S March 14, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of ChemoMetec A/S help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ChemoMetec AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of ChemoMetec AS based on widely used predictive technical indicators. In general, we focus on analyzing ChemoMetec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ChemoMetec A/S's daily price indicators and compare them against related drivers.

Complementary Tools for ChemoMetec Stock analysis

When running ChemoMetec A/S's price analysis, check to measure ChemoMetec A/S's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec A/S is operating at the current time. Most of ChemoMetec A/S's value examination focuses on studying past and present price action to predict the probability of ChemoMetec A/S's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec A/S's price. Additionally, you may evaluate how the addition of ChemoMetec A/S to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios